Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7901)
All Articles published online
|
Publishing Process of This Article
|
Dec 21, 2013 (publication date) through Feb 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhu Y, Chen S. Antiviral treatment of hepatitis C virus infection and factors affecting efficacy. World J Gastroenterol 2013; 19(47): 8963-8973 [PMID: 24379621 DOI: 10.3748/wjg.v19.i47.8963] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i47/8963.htm |
| Number | Citing Articles |
| 1 |
Vanessa Costilla, Neha Mathur, Julio A. Gutierrez. Mechanisms of Virologic Failure with Direct-Acting Antivirals in Hepatitis C and Strategies for Retreatment. Clinics in Liver Disease 2015; 19(4): 641 doi: 10.1016/j.cld.2015.06.005
|
| 2 |
Satoshi Hiramine, Norihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta, Eiji Kajiwara, Hideyuki Nomura, Kazufumi Dohmen, Kazuhiro Takahashi, Takeaki Satoh, Koichi Azuma, Akira Kawano, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi. Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis C. World Journal of Hepatology 2015; 7(26): 2688-2695 doi: 10.4254/wjh.v7.i26.2688
|
| 3 |
Cristina Romero-López, Alfredo Berzal-Herranz. Structure-function relationship in viral RNA genomes: The case of hepatitis C virus. World Journal of Medical Genetics 2014; 4(2): 6-18 doi: 10.5496/wjmg.v4.i2.6
|
| 4 |
Jorge Soares, António Ferreira, André Silva-Pinto, Francisco Almeida, Carmela Piñeiro, Rosário Serrão, António Sarmento. The Influence of Antiretroviral Therapy on Hepatitis C Virus Viral Load and Liver Fibrosis in Human Immunodeficiency Virus-Coinfected Patients: An Observational Study. Intervirology 2019; 62(5-6): 182 doi: 10.1159/000503631
|
| 5 |
Patrick Arbuthnot. Gene Therapy for Viral Infections. 2015; : 1 doi: 10.1016/B978-0-12-410518-8.00001-6
|
| 6 |
Jean-Jacques Tudesq, Catherine Dunyach-Remy, Christophe Combescure, Régine Doncesco, Didier Laureillard, Jean-Philippe Lavigne, Albert Sotto, Cristian Apetrei. Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients. PLOS ONE 2017; 12(9): e0183372 doi: 10.1371/journal.pone.0183372
|
| 7 |
Jong Eun Yeon. Treatment of Chronic Hepatitis C in Older Adults. Korean Journal of Clinical Geriatrics 2023; 24(3): 93 doi: 10.15656/kjcg.2023.24.3.93
|
| 8 |
Ludovico Abenavoli, Mario Masarone, Valentina Peta, Natasa Milic, Nazarii Kobyliak, Samir Rouabhia, Marcello Persico. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World Journal of Gastroenterology 2014; 20(41): 15233-15240 doi: 10.3748/wjg.v20.i41.15233
|
| 9 |
Sara Corchado, Luis F. López-Cortés, Antonio Rivero-Juárez, Almudena Torres-Cornejo, Antonio Rivero, Mercedes Márquez-Coello, José-Antonio Girón-González, Wenyu Lin. Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients. PLoS ONE 2014; 9(7): e101760 doi: 10.1371/journal.pone.0101760
|
| 10 |
XIAO-HUA JIANG, YU-TAO XIE, BO JIANG, MENG-YING TANG, TAO MA, HUA PENG. Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAs. Molecular Medicine Reports 2015; 12(2): 1905 doi: 10.3892/mmr.2015.3571
|
| 11 |
Robert Flisiak, Mitchell Shiffman, Juan Arenas, Hugo Cheinquer, Igor Nikitin, Yuping Dong, Khurram Rana, Subasree Srinivasan, Chien-Wei Su. A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C. PLOS ONE 2016; 11(10): e0164563 doi: 10.1371/journal.pone.0164563
|
| 12 |
Patrick Arbuthnot. Gene Therapy for Viral Infections. 2015; : 191 doi: 10.1016/B978-0-12-410518-8.00007-7
|
| 13 |
Zeynep Altın, Gülden Diniz, Ayfer Çolak, Betül Koyuncu, Serhat Özer, Fatih Aslan, Belkıs Ünsal. Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C. Turkish Journal of Biochemistry 2019; 44(2): 170 doi: 10.1515/tjb-2018-0163
|
| 14 |
Hye Jin Yang, Ju Yeon Ryoo, Bong Kyu Yoo. Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection. International Journal of Clinical Pharmacy 2015; 37(5): 698 doi: 10.1007/s11096-015-0144-x
|
| 15 |
THT Nguyen, J Guedj. HCV Kinetic Models and Their Implications in Drug Development. CPT: Pharmacometrics & Systems Pharmacology 2015; 4(4): 231 doi: 10.1002/psp4.28
|
| 16 |
Mohsen Koolivand, Zeinab Allamehzadeh, Ali Ahmadi, Ramezan Ali Taheri, Kazem Hassanpour, Afshin Zeini, Gholamreza Farnoosh. The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran. Jundishapur Journal of Microbiology 2020; 13(5) doi: 10.5812/jjm.95798
|
| 17 |
Min Gu Kang, Min Jung Kang, Eunhee Ji, Bong Kyu Yoo. Meta-analysis of the Efficacy and Safety of Grazoprevir and Elbasvir for the Treatment of Hepatitis C Virus Infection. Korean Journal of Clinical Pharmacy 2017; 27(3): 150 doi: 10.24304/kjcp.2017.27.3.150
|
| 18 |
Yuan-Hung Kuo, Pao-Fei Chen, Jing-Houng Wang, Kuo-Chin Chang, Kwong-Ming Kee, Ming-Chao Tsai, Chun-Yin Lin, Sheng-Che Lin, Lin-San Tsai, Shu-Chuan Chen, Sheng-Nan Lu, Chen-Hua Liu. Comparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care. PLOS ONE 2015; 10(5): e0126031 doi: 10.1371/journal.pone.0126031
|
| 19 |
Partha K. Chandra, Feyza Gunduz, Sidhartha Hazari, Ramazan Kurt, Rajesh Panigrahi, Bret Poat, David Bruce, Ari J. Cohen, Humberto E. Behorquez, Ian Carmody, George Loss, Luis A. Balart, Tong Wu, Srikanta Dash, Ranjit Ray. Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis. PLoS ONE 2014; 9(9): e108616 doi: 10.1371/journal.pone.0108616
|
| 20 |
Victoria Belousova, Ahmed A. Abd-Rabou, Shaker A. Mousa. Recent advances and future directions in the management of hepatitis C infections. Pharmacology & Therapeutics 2015; 145: 92 doi: 10.1016/j.pharmthera.2014.09.002
|
| 21 |
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
|
| 22 |
Alexis Jose-Abrego, Maria E. Trujillo-Trujillo, Saul Laguna-Meraz, Sonia Roman, Arturo Panduro. Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis. Pathogens 2024; 13(5): 360 doi: 10.3390/pathogens13050360
|
| 23 |
Jun Itakura, Masayuki Kurosaki, Hitomi Takada, Natsuko Nakakuki, Syuya Matsuda, Kouichi Gondou, Yu Asano, Nobuhiro Hattori, Yoshie Itakura, Nobuharu Tamaki, Yutaka Yasui, Shoko Suzuki, Takanori Hosokawa, Kaoru Tsuchiya, Hiroyuki Nakanishi, Yuka Takahashi, Syinya Maekawa, Nobuyuki Enomoto, Namiki Izumi. Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy. Hepatology Research 2015; 45(10) doi: 10.1111/hepr.12474
|
| 24 |
Poor Response to Direct-Acting Antiviral Therapy in HCV-Infected Elderly Population: A Real-Life Cohort Study Based on GeneXpert
®
Technology
. Future Virology 2018; 13(7): 467 doi: 10.2217/fvl-2017-0158
|
| 25 |
Holly Hagan, Joshua Neurer, Ashly E Jordan, Don C Des Jarlais, Jennifer Wu, Kirk Dombrowski, Bilal Khan, Ronald Scott Braithwaite, Jason Kessler. Hepatitis C virus infection among HIV-positive men who have sex with men: protocol for a systematic review and meta-analysis. Systematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-31
|
| 26 |
Dur E Nishwa, Hafiza Arooba Riaz, Muhammad Salman Tiwana, Ameer Fatima, Braira Wahid. Treatment response and adverse effects of direct acting antivirals among HCV patients carrying comorbid conditions. Future Virology 2024; 19(2-4): 77 doi: 10.2217/fvl-2023-0193
|
| 27 |
Zehui Yan, Yuming Wang. Viral and host factors associated with outcomes of hepatitis C virus infection. Molecular Medicine Reports 2017; 15(5): 2909 doi: 10.3892/mmr.2017.6351
|
| 28 |
Lei Chen, Jing Lu, Tao Huang, Jun Yin, Lai Wei, Yu-Dong Cai, Lisa F. P. Ng. Finding Candidate Drugs for Hepatitis C Based on Chemical-Chemical and Chemical-Protein Interactions. PLoS ONE 2014; 9(9): e107767 doi: 10.1371/journal.pone.0107767
|
| 29 |
Braira Wahid, Shazia Rafique, Komal Saleem, Amjad Ali, Muhammad Idrees. An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load. Journal of Interferon & Cytokine Research 2018; 38(3): 122 doi: 10.1089/jir.2017.0129
|
| 30 |
Naveen Tmu, Ashish Kumar, Praveen Sharma, Vikas Singla, Naresh Bansal, Anil Arora. Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis. Journal of Clinical and Experimental Hepatology 2019; 9(1): 4 doi: 10.1016/j.jceh.2018.02.009
|
| 31 |
Nobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo. Asunaprevir (BMS-650032) for the treatment of hepatitis C virus. Expert Review of Anti-infective Therapy 2015; 13(11): 1307 doi: 10.1586/14787210.2015.1091724
|
| 32 |
Lourianne Nascimento Cavalcante, André Castro Lyra. Predictive factors associated with hepatitis C antiviral therapy response. World Journal of Hepatology 2015; 7(12): 1617-1631 doi: 10.4254/wjh.v7.i12.1617
|
| 33 |
Raíssa Neves Fagundes, Lincoln Eduardo Villela Vieira de Castro Ferreira, Fábio Heleno de Lima Pace. Health-Related Quality of Life in patients with hepatitis C in double and triple therapy. Revista da Escola de Enfermagem da USP 2015; 49(6): 937 doi: 10.1590/S0080-623420150000600009
|
| 34 |
Kattareeya Kumthip, Niwat Maneekarn. The role of HCV proteins on treatment outcomes. Virology Journal 2015; 12(1) doi: 10.1186/s12985-015-0450-x
|
| 35 |
Eleanor M. Wilson, Elana S. Rosenthal, Sarah Kattakuzhy, Lydia Tang, Shyam Kottilil. Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C. Clinical Microbiology Reviews 2017; 30(1): 23 doi: 10.1128/CMR.00037-16
|
| 36 |
Shagufta Kamal, Asif Shahzad, Kanwal Rehman, Komal Tariq, Muhammad Sajid Hamid Akash, Muhammad Imran, Mohammed Ali Assiri. Therapeutic Intervention of Serine Protease Inhibitors against
Hepatitis C Virus. Current Medicinal Chemistry 2024; 31(15): 2052 doi: 10.2174/0109298673234823230921090431
|
| 37 |
Zhen-Xi Niu, Peng Nie, Piet Herdewijn, Ya-Tao Wang. Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis. European Journal of Medicinal Chemistry 2023; 262: 115919 doi: 10.1016/j.ejmech.2023.115919
|